Nisa Investment Advisors
BPMC

Nisa Investment Advisors’s Blueprint Medicines BPMC Stock Holding History

Nisa Investment Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,950
Closed -$250K – 2995
2025
Q2 		$250K Buy
1,950
+3
+0.2% +$312 ﹤0.01% 1162
2025
Q1 		$172K Buy
1,947
+90
+5% +$8.78K ﹤0.01% 1262
2024
Q4 		$162K Sell
1,857
-36
-2% -$3.3K ﹤0.01% 1348
2024
Q3 		$175K Sell
1,893
-148
-7% -$14.7K ﹤0.01% 1306
2024
Q2 		$220K Buy
2,041
+50
+3% +$5K ﹤0.01% 1284
2024
Q1 		$189K Buy
1,991
+51
+3% +$4.37K ﹤0.01% 1316
2023
Q4 		$179K Sell
1,940
-90
-4% -$5.83K ﹤0.01% 1298
2023
Q3 		$102K Hold
2,030
– – ﹤0.01% 1497
2023
Q2 		$128K Buy
2,030
+425
+26% +$23.1K ﹤0.01% 1449
2023
Q1 		$72K Buy
1,605
+983
+158% +$44.3K ﹤0.01% 1602
2022
Q4 		$27K Sell
622
-9
-1% -$432 ﹤0.01% 1963
2022
Q3 		$33K Sell
631
-53
-8% -$3.4K ﹤0.01% 1894
2022
Q2 		$35K Buy
684
+230
+51% +$13.5K ﹤0.01% 1861
2022
Q1 		$29K Sell
454
-2,914
-87% -$209K ﹤0.01% 1976
2021
Q4 		$260K Buy
3,368
+1,025
+44% +$107K ﹤0.01% 1196
2021
Q3 		$241 Sell
2,343
-1,813
-44% -$169K ﹤0.01% 1338
2021
Q2 		$366 Hold
4,156
– – ﹤0.01% 1220
2021
Q1 		$404 Hold
4,156
– – ﹤0.01% 1227
2020
Q4 		$466K Buy
4,156
+2,336
+128% +$246K ﹤0.01% 1181
2020
Q3 		$169K Buy
1,820
+1,360
+296% +$105K ﹤0.01% 1359
2020
Q2 		$36K Buy
460
+90
+24% +$6.09K ﹤0.01% 1647
2020
Q1 		$22K Sell
370
-90
-20% -$5.79K ﹤0.01% 1691
2019
Q4 		$37K Buy
460
+180
+64% +$13.5K ﹤0.01% 1579
2019
Q3 		$21K Buy
280
+80
+40% +$6.92K ﹤0.01% 1630
2019
Q2 		$19K Hold
200
– – ﹤0.01% 1610
2019
Q1 		$16K Hold
200
– – ﹤0.01% 1647
2018
Q4 		$11K Hold
200
– – ﹤0.01% 1622
2018
Q3 		$16K Hold
200
– – ﹤0.01% 1585
2018
Q2 		$13K Hold
200
– – ﹤0.01% 1645
2018
Q1 		$18K Sell
200
-100
-33% -$8.62K ﹤0.01% 1496
2017
Q4 		$23K Hold
300
– – ﹤0.01% 1518
2017
Q3 		$21K Buy
+300
New +$16K ﹤0.01% 1513

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nisa Investment Advisors's BPMC Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,950 shares — an estimated $250K sold.

Nisa Investment Advisors first reported a position in BPMC in Q3 2017 and held it in 32 quarters. The position peaked at $466K in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,950 Blueprint Medicines shares in Q3 2025, an estimated $250K.
  • Nisa Investment Advisors first reported a position in Blueprint Medicines in Q3 2017 and held it in 32 quarters.
  • Nisa Investment Advisors's Blueprint Medicines position peaked at $466K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.